Survival and Prognostic Factors in Patients with Brain Metastases from Malignant Melanoma
Oncology Research and Treatment2004Vol. 27(2), pp. 145–149
Citations Over TimeTop 10% of 2004 papers
Stéphanie Meier, Brigitta G. Baumert, Tanja Maier, G. Wellis, Günter Burg, Burkhardt Seifert, Reinhard Dummer
Abstract
Radiotherapy, chemotherapy and especially surgery and stereotactic radiosurgery seem to significantly prolong survival, as shown by multivariate analysis. Treatment with temozolomide will possibly play an important role in the future management of patients with brain metastases from cutaneous melanoma, but further prospective studies to verify this assumption are urgently needed.
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)